Epidemiology and Risk Factors of Candidemia a 8-Year Retrospective Study from a Teaching Hospital in China

References

• Zaoutis TE, Argon J, Chu J, et al. The epidemiology and attributable outcomes of candidemia in adults and children hospitalized in the United States: A propensity analysis. Clin Infect Dis. 2005;41(9):1232–1239. doi:10.1086/496922
   PubMed Web of Science ®Google Scholar
• Morgan J, Meltzer MI, Plikaytis BD, et al. Excess mortality, hospital stay, and cost due to candidemia: a case-control study using data from population-based candidemia surveillance. Infect Control Hosp Epidemiol. 2005;26(6):540–547. doi:10.1086/502581
   PubMed Web of Science ®Google Scholar
• Hassan I, Powell G, Sidhu M, et al. Excess mortality, length of stay and cost attributable to candidaemia. J Infect. 2009;59(5):360–365. doi:10.1099/0022-1317-51-2-110
   PubMed Web of Science ®Google Scholar
• Shorr AF, Gupta V, Sun X, et al. Burden of early-onset candidemia: analysis of culture-positive bloodstream infections from a large U.S. database. Crit Care Med. 2009;37(9):2519–2535. doi:10.1097/CCM.0b013e3181a0f95d
   PubMed Web of Science ®Google Scholar
• Zhang W, Song X, Wu H, Zheng R. Epidemiology, risk factors and outcomes of Candida albicans vs. non-albicans  candidaemia in adult patients in Northeast China. Epidemiol Infect. 2019;147:e277. doi:10.1017/S0950268819001638
   PubMed Web of Science ®Google Scholar
• Ye N, Liu Z, Tang W, et al. Systematic Characterization of Epidemiology, Antifungal Susceptibility, Risk Factors and Outcomes of Candidaemia: A Six-Year Chinese Study. Infect Drug Resist. 2022;15:4887–4888. doi:10.2147/IDR.S378629
   PubMed Web of Science ®Google Scholar
• Kutlu M, Sayın-Kutlu S, Alp-çavuş S, et al. Mortality-associated factors of candidemia: a multi-center prospective cohort in Turkey. Eur J Clin Microbiol Infect Dis. 2022;41(4):597–607. doi:10.1007/s10096-021-04394-0
   PubMed Web of Science ®Google Scholar
• Schroeder M, Weber T, Denker T, et al. Epidemiology, clinical characteristics, and outcome of candidemia in critically ill patients in Germany: a single-center retrospective 10-year analysis. Ann Intensive Care. 2020;10(1):142. doi:10.1186/s13613-020-00755-8
   PubMed Web of Science ®Google Scholar
• Xiao M, Chen SC, Kong F, et al. Distribution and antifungal susceptibility of candida species causing candidemia in china: An Update From the CHIF-NET Study. J Infect Dis. 2020;221(2):S139–S147. doi:10.1007/s00134-014-3400-y
   PubMedGoogle Scholar
• Ko JH, Jung DS, Lee JY, et al. Poor prognosis of Candida tropicalis among non-albicans candidemia: a retrospective multicenter cohort study, Korea. Diagn Microbiol Infect Dis. 2019;95(2):195–200. doi:10.1016/j.diagmicrobio.2019.05.017
   PubMed Web of Science ®Google Scholar
• Doğan Ö, Yeşilkaya A, Menekşe Ş, et al. Effect of initial antifungal therapy on mortality among patients with bloodstream infections with different Candida species and resistance to antifungal agents: a multicentre observational study by the Turkish Fungal Infections Study Group. Int J Antimicrob Agents. 2020;56(1):105992. doi:10.1016/j.ijantimicag.2020.105992
   PubMed Web of Science ®Google Scholar
• Richardson MD. Changing patterns and trends in systemic fungal infections. J Antimicrob Chemother. 2005;56(1):i5–i11. doi:10.1093/jac/dki218
   PubMedGoogle Scholar
• Krcmery V, Laho L, Huttova M, et al. Aetiology, antifungal susceptibility, risk factors and outcome in 201 fungaemic children: data from a 12-year prospective national study from Slovakia. J Med Microbiol. 2002;51(2):110–116. doi:10.1099/0022-1317-51-2-110
   PubMed Web of Science ®Google Scholar
• Lee YM, Kim DY, Kim YJ, Park KH, Lee MS. Clinical impacts of delayed central venous catheter removal according to the severity of comorbidities in patients with candidaemia. J Hosp Infect. 2019;103(4):420–427. doi:10.1016/j.jhin.2019.08.018
   PubMed Web of Science ®Google Scholar
• Andes DR, Safdar N, Baddley JW, et al. Impact of treatment strategy on outcomes in patients with candidemia and other forms of invasive candidiasis: a patient-level quantitative review of randomized trials. Clin Infect Dis. 2012;54(8):1110–1122. doi:10.1093/cid/cis021
   PubMed Web of Science ®Google Scholar
• Colombo AL, Guimarães T, Sukienik T, et al. Prognostic factors and historical trends in the epidemiology of candidemia in critically ill patients: an analysis of five multicenter studies sequentially conducted over a 9-year period. Intensive Care Med. 2014;40(10):1489–1498. doi:10.1007/s00134-014-3400-y
   PubMed Web of Science ®Google Scholar
• Mitchell KF, Zarnowski R, Sanchez H, et al. Community participation in biofilm matrix assembly and function. Proc Natl Acad Sci U S A. 2015;112(13):4092–4097. doi:10.1073/pnas.1421437112
   PubMed Web of Science ®Google Scholar
• Atiencia-Carrera MB, Cabezas-Mera FS, Tejera E, Machado A, Saokaew S. Prevalence of biofilms in Candida spp. bloodstream infections: a meta-analysis. PLoS One. 2022;17(2):e0263522. doi:10.1371/journal.pone.0263522
   PubMed Web of Science ®Google Scholar
• Clinical and Laboratory Standards Institute. Performance Standards for Antifungal Susceptibility Testing of Yeasts, M60. Clinical and Laboratory Standards Institute; 2020.
   Google Scholar
• Lausch KR, Søgaard M, Rosenvinge FS, et al. High incidence of candidaemia in a nationwide cohort: underlying diseases, risk factors and mortality. Int J Infect Dis. 2018;76:58–63. doi:10.1016/j.ijid.2018.08.010
   PubMed Web of Science ®Google Scholar
• Li Y, Gu C, Yang Y, et al. Epidemiology, antifungal susceptibility, risk factors, and mortality of persistent candidemia in adult patients in China: a 6-year multicenter retrospective study. BMC Infect Dis. 2023;23(1):369. doi:10.1186/s12879-023-08241-9
   PubMed Web of Science ®Google Scholar
• Kim JH, Suh JW, Kim MJ. Epidemiological Trends of Candidemia and the Impact of Adherence to the Candidemia Guideline: six-Year Single-Center Experience. J Fungi. 2021;7(4):275. doi:10.3390/jof7040275
   Web of Science ®Google Scholar
• Toda M, Williams SR, Berkow EL, et al. Population-Based Active Surveillance for Culture-Confirmed Candidemia - Four Sites, United States, 2012-2016. MMWR Surveill Summ. 2019;68(8):1–15. doi:10.15585/mmwr.ss6808a1
   PubMed Web of Science ®Google Scholar
• Tsukamoto H, Higashi T, Kodawara T, et al. A longitudinal study of Candida bloodstream infections in a Japanese university hospital: species distribution, drug susceptibility, clinical features, and mortality predictors. Eur J Clin Microbiol Infect Dis. 2022;41(11):1315–1325. doi:10.1007/s10096-022-04499-0
   PubMed Web of Science ®Google Scholar
• Castanheira M, Deshpande LM, Messer SA, Rhomberg PR, Pfaller MA. Analysis of global antifungal surveillance results reveals predominance of Erg11 Y132F alteration among azole-resistant Candida parapsilosis and Candida tropicalis and country-specific isolate dissemination. Int J Antimicrob Agents. 2020;55(1):105799. doi:10.1016/j.ijantimicag.2019.09.003
   PubMed Web of Science ®Google Scholar
• Keighley C, Gall M, van Hal SJ, et al. Whole genome sequencing shows genetic diversity, as well as clonal complex and gene polymorphisms associated with fluconazole non-susceptible isolates of candida tropicalis. J Fungi. 2022;8(9):896. doi:10.3390/jof8090896
   Web of Science ®Google Scholar
• Liu WL, Huang YT, Hsieh MH, et al. Clinical characteristics of Candida tropicalis fungaemia with reduced triazole susceptibility in Taiwan: a multicentre study. Int J Antimicrob Agents. 2019;53(2):185–189. doi:10.1016/j.ijantimicag.2018.10.015
   PubMed Web of Science ®Google Scholar
• Fan X, Xiao M, Liao K, et al. Notable Increasing Trend in Azole Non-susceptible Candida tropicalis Causing Invasive Candidiasis in China Molecular Epidemiology and Clinical Azole Consumption. Front Microbiol. 2017;8:464. doi:10.3389/fmicb.2017.00464
   PubMed Web of Science ®Google Scholar
• Liu F, Zhong L, Zhou F, et al. Clinical Features, Strain Distribution, Antifungal Resistance and Prognosis of Patients with Non-albicans Candidemia: a Retrospective Observational Study. Infect Drug Resist. 2021;14:3233–3246. doi:10.2147/IDR.S323583
   PubMed Web of Science ®Google Scholar
• Ngamchokwathana C, Chongtrakool P, Waesamaae A, Chayakulkeeree M. Risk Factors and Outcomes of Non-albicans Candida Bloodstream Infection in Patients with Candidemia at Siriraj Hospital-Thailand’s Largest National Tertiary Referral Hospital. J Fungi. 2021;7(4):269. doi:10.3390/jof7040269
   Web of Science ®Google Scholar
• Bourassa-Blanchette S, Biesheuvel MM, Lam JC, et al. Incidence, susceptibility and outcomes of candidemia in adults living in Calgary. BMC Infect Dis. 2023;23(1):100. doi:10.1186/s12879-023-08050-0
   PubMed Web of Science ®Google Scholar
• Meyahnwi D, Siraw BB, Reingold A. Epidemiologic features, clinical characteristics, and predictors of mortality in patients with candidemia in Alameda County, California; a 2017-2020 retrospective analysis. BMC Infect Dis. 2022;22(1):843. doi:10.1186/s12879-022-07848-8
   PubMed Web of Science ®Google Scholar
• Qiao Y, Tao Z, Hao F, et al. Epidemiological Characteristics, Antifungal Susceptibility, Risk Factors, and Outcomes of Candida Bloodstream Infection: a Ten-Year Surveillance in a Teaching Hospital in China. Infect Drug Resist. 2023;16:4769–4778. doi:10.2147/IDR.S411283
   PubMed Web of Science ®Google Scholar
• El Zakhem A, El Eid R, Istambouli R, Tamim H, Kanj SS. The Utility of EQUAL Candida Score in Predicting Mortality in Patients with Candidemia. J Fungi. 2022;8(3):238. doi:10.3390/jof8030238
   Web of Science ®Google Scholar
• Kato H, Yoshimura Y, Suido Y, et al. Mortality and risk factor analysis for Candida blood stream infection: a multicenter study. J Infect Chemother. 2019;25(5):341–345. doi:10.1016/j.jhin.2019.08.018
   PubMed Web of Science ®Google Scholar
• Poissy J, Damonti L, Bignon A, et al. Risk factors for candidemia: a prospective matched case-control study. Crit Care. 2020;24(1):109. doi:10.1186/s13054-020-2766-1
   PubMed Web of Science ®Google Scholar
• Nucci M, Anaissie E, Betts RF, et al. Early removal of central venous catheter in patients with candidemia does not improve outcome: analysis of 842 patients from 2 randomized clinical trials. Clin Infect Dis. 2010;51(3):295–303. doi:10.1086/653935
   PubMed Web of Science ®Google Scholar
• Grim SA, Berger K, Teng C, et al. Timing of susceptibility-based antifungal drug administration in patients with Candida bloodstream infection: correlation with outcomes. J Antimicrob Chemother. 2012;67(3):707–714. doi:10.1093/jac/dkr511
   PubMed Web of Science ®Google Scholar
• Nucci M, Braga PR, Nouér SA, Anaissie E. Time of catheter removal in candidemia and mortality. Braz J Infect Dis. 2018;22:455–461. doi:10.1016/j.bjid.2018.10.278
   PubMed Web of Science ®Google Scholar
• Tedeschi S, Tumietto F, Giannella M, et al. Epidemiology and outcome of candidemia in internal medicine wards: a regional study in Italy. Eur J Intern Med. 2016;34:39–44. doi:10.1016/j.ejim.2016.08.020
   PubMed Web of Science ®Google Scholar
• Zheng YJ, Xie T, Wu L, et al. Epidemiology, species distribution, and outcome of nosocomial Candida spp. bloodstream infection in Shanghai: an 11-year retrospective analysis in a tertiary care hospital. Ann Clin Microbiol Antimicrob. 2021;20(1):34. doi:10.1186/s12941-021-00441-y
   PubMed Web of Science ®Google Scholar
• Gao Y, Tang M, Li Y, et al. Machine-learning based prediction and analysis of prognostic risk factors in patients with candidemia and bacteraemia: a 5-year analysis. PeerJ. 2022;10:e13594. doi:10.7717/peerj.13594
   PubMed Web of Science ®Google Scholar
• Fernández-Ruiz M, Puig-Asensio M, Guinea J, et al. Candida tropicalis bloodstream infection: incidence, risk factors and outcome in a population-based surveillance. J Infect. 2015;71(3):385–394. doi:10.1016/j.jinf.2015.05.009
   PubMed Web of Science ®Google Scholar